“Ozempic ruins your metabolism — once you take it, your metabolism is permanently damaged and you'll gain all the weight back (and then some) the moment you stop.”
What the evidence shows
Any substantial weight loss — by any method — lowers your resting calorie burn, partly because a smaller body needs less fuel and partly through "adaptive thermogenesis"; this is normal physiology, not unique drug damage. After stopping semaglutide, appetite and weight tend to return: in the STEP 1 trial extension, people regained about two-thirds of their lost weight within a year and most cardiometabolic improvements drifted back toward baseline. Some trial data (e.g., the SEMALEAN study) show resting energy expenditure dips during active loss but recovers relative to lean mass over time, not evidence of a permanently "broken" metabolism.
What we still don’t know
There is no good evidence that GLP-1 medicines cause lasting, irreversible metabolic damage beyond the expected adaptation that follows weight loss of any kind. How fully resting metabolic rate recovers, and for whom, after long-term use and regain is still not well mapped — especially when significant muscle is lost along the way.
Why the claim misleads
It mislabels two normal, well-documented things — the metabolic slowdown that accompanies any weight loss, and weight regain when an appetite-acting drug is stopped — as permanent "ruin" caused by the drug. The framing hides the real and modifiable issue: losing muscle (not just fat) lowers metabolism, which is why protein intake and resistance training during weight loss matter, regardless of whether a medication is involved.
Graded by The Peptide Era · evidence, not hype